Compounds > oseltamivir
Page last updated: 2024-08-24

oseltamivir and a 315675

oseltamivir has been researched along with a 315675 in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kati, WM; Kempf, DJ; Kohlbrenner, WE; Krueger, AC; Maring, CJ; McDaniel, KF; Molla, A; Montgomery, D; Xu, Y1
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E1
Demmler-Harrison, GJ; Deyde, VM; Gubareva, LV; Klimov, AI; Okomo-Adhiambo, M; Sheu, TG; Xu, X1
Gubareva, LV; Klimov, AI; Mishin, VP; Nguyen, HT; Sheu, TG1
Carrick, R; Gubareva, L; Hayden, F; Kati, WM; Kempf, D; Kohlbrenner, W; Maring, C; McDaniel, K; Molla, A; Montgomery, D; Steffy, K1
Carrick, R; Gusick, N; Kati, W; Kempf, DJ; Kohlbrenner, W; Maring, C; Molla, A; Montgomery, D; Ng, TI; Shi, Y; Steffy, K; Stewart, KD; Stoll, VS1
Abed, Y; Baz, M; Boivin, G; Nehmé, B1
Abed, Y; Boivin, G; Bouhy, X; Pizzorno, A1
Deyde, VM; Fry, AM; Garten, RJ; Gubareva, LV; Klimov, AI; Mishin, VP; Nguyen, HT; Okomo-Adhiambo, M; Shaw, MW; Sheu, TG; Sleeman, K; Trujillo, AA1
Li, JF; Shen, JS; Xiong, RS; Zhang, Q; Zhao, QJ1

Reviews

1 review(s) available for oseltamivir and a 315675

ArticleYear
[Research progress of anti-influenza virus agents].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2010, Volume: 45, Issue:3

    Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Guanidines; Humans; Indoles; Influenza, Human; Neuraminidase; Orthomyxoviridae; Oseltamivir; Pyrrolidines; Rimantadine; Structure-Activity Relationship; Viral Matrix Proteins; Zanamivir

2010

Other Studies

9 other study(ies) available for oseltamivir and a 315675

ArticleYear
Synthesis of potent pyrrolidine influenza neuraminidase inhibitors.
    Bioorganic & medicinal chemistry letters, 2008, Mar-01, Volume: 18, Issue:5

    Topics: Antiviral Agents; Influenza A virus; Influenza B virus; Molecular Structure; Neuraminidase; Pyrrolidines; Structure-Activity Relationship

2008
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2

    Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship

2009
Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Antiviral Agents; Cells, Cultured; Child, Preschool; Drug Resistance, Viral; Genetic Testing; Humans; Immunocompromised Host; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Molecular Sequence Data; Neuraminidase; Oseltamivir; Point Mutation; Sequence Analysis, DNA

2010
Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Acids, Carbocyclic; Animals; Cell Line; Cyclopentanes; Dogs; Enzyme Assays; Enzyme Inhibitors; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Inhibitory Concentration 50; Neuraminidase; Oseltamivir; Zanamivir

2010
In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:4

    Topics: Acetamides; Algorithms; Animals; Antiviral Agents; Cell Line; Dogs; Enzyme Inhibitors; Influenza A virus; Influenza B virus; Kinetics; Neuraminidase; Oseltamivir; Pyrrolidines; Viral Plaque Assay; Virus Replication

2002
In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.
    Journal of virology, 2002, Volume: 76, Issue:11

    Topics: Acetamides; Animals; Antiviral Agents; Cell Line; Dogs; Drug Resistance, Viral; Enzyme Inhibitors; Genetic Variation; Guanidines; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A virus; Mutagenesis; Neuraminidase; Oseltamivir; Phenotype; Pyrans; Pyrrolidines; Sialic Acids; Zanamivir

2002
Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
    Antiviral research, 2008, Volume: 77, Issue:2

    Topics: Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Inhibitory Concentration 50; Mutation; Neuraminidase; Oseltamivir; Pyrrolidines; Recombinant Proteins; Transfection

2008
Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.
    The Journal of infectious diseases, 2011, Jan-01, Volume: 203, Issue:1

    Topics: Acids, Carbocyclic; Amino Acid Substitution; Antiviral Agents; Cyclopentanes; Drug Resistance, Viral; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Neuraminidase; Oseltamivir; Pyrrolidines; Recombination, Genetic; Viral Plaque Assay; Viral Proteins; Virus Replication; Zanamivir

2011
Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
    Antiviral therapy, 2010, Volume: 15, Issue:8

    Topics: Acids, Carbocyclic; Adamantane; Amino Acid Substitution; Animals; Antiviral Agents; Cell Line; Cyclopentanes; Dogs; Drug Resistance, Viral; Enzyme Inhibitors; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Neuraminidase; Oseltamivir; Pyrans; Pyrrolidines; Sialic Acids; Viral Plaque Assay; Zanamivir

2010